Literature DB >> 22005651

Genetic association between ghrelin polymorphisms and Alzheimer's disease in a Japanese population.

Nobuto Shibata1, Tohru Ohnuma, Bolati Kuerban, Miwa Komatsu, Heii Arai.   

Abstract

BACKGROUND/AIMS: Ghrelin has been reported to enter the hippocampus and to bind to the neurons of the hippocampal formation. This peptide also affects neuronal glucose uptake and decreases tau hyperphosphorylation. There is increasing evidence suggesting an association between ghrelin and Alzheimer's disease (AD) pathology. The aim of this study was to investigate whether single nucleotide polymorphisms (SNPs) of the ghrelin gene are associated with AD.
METHODS: The SNPs were genotyped using TaqMan technology and were analyzed using a case-control study design. Our case-control dataset consisted of 182 AD patients and 143 age-matched controls.
RESULTS: Hardy-Weinberg equilibrium and linkage disequilibrium analyses suggest that the region in and around the gene is highly polymorphic. One SNP, rs4684677 (Leu90Gln), showed a marginal association with age of AD onset. We did not detect any association between the other SNPs of the ghrelin gene and AD.
CONCLUSION: There have been few genetic studies on the relationship between circulating ghrelin and functional SNPs. Further multifactorial studies are needed to clarify the relationship between ghrelin and AD.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22005651     DOI: 10.1159/000333075

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  6 in total

1.  Plasma BDNF levels are correlated with aggressiveness in patients with amnestic mild cognitive impairment or Alzheimer disease.

Authors:  Tomoyuki Nagata; Nobuyuki Kobayashi; Shunichiro Shinagawa; Hisashi Yamada; Kazuhiro Kondo; Kazuhiko Nakayama
Journal:  J Neural Transm (Vienna)       Date:  2013-11-20       Impact factor: 3.575

Review 2.  Ghrelin and Neurodegenerative Disorders-a Review.

Authors:  Limin Shi; Xixun Du; Hong Jiang; Junxia Xie
Journal:  Mol Neurobiol       Date:  2016-01-26       Impact factor: 5.590

Review 3.  Therapeutic Potential of Targeting the Ghrelin Pathway.

Authors:  Gustav Colldén; Matthias H Tschöp; Timo D Müller
Journal:  Int J Mol Sci       Date:  2017-04-11       Impact factor: 5.923

4.  Association of plasma ghrelin levels and ghrelin rs4684677 polymorphism with mild cognitive impairment in type 2 diabetic patients.

Authors:  Rong Huang; Jing Han; Sai Tian; Rongrong Cai; Jie Sun; Yanjue Shen; Shaohua Wang
Journal:  Oncotarget       Date:  2017-02-28

5.  Design and Experimental Evaluation of a Peptide Antagonist against Amyloid β(1-42) Interactions with Calmodulin and Calbindin-D28k.

Authors:  Jairo Salazar; Joana Poejo; Ana M Mata; Alejandro K Samhan-Arias; Carlos Gutierrez-Merino
Journal:  Int J Mol Sci       Date:  2022-02-18       Impact factor: 5.923

Review 6.  Neuropeptides Exert Neuroprotective Effects in Alzheimer's Disease.

Authors:  Xin-Yi Chen; Yi-Feng Du; Lei Chen
Journal:  Front Mol Neurosci       Date:  2019-01-11       Impact factor: 5.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.